Inotek Pharmaceuticals, Corp. (NASDAQ:ITEK) Craters Over 71% Following Failure of Phase 3 Trial

Inotek Pharmaceuticals, Corp. (NASDAQ:ITEK) Craters Over 71% Following Failure of Phase 3 Trial

Clinical-stage biopharmaceutical company focused on diseases of the eye, Inotek Pharmaceuticals, Corp. (NASDAQ:ITEK), goes in the tank after failure of Phase 3 trial.  Investors in Inotek Pharmaceuticals (NASDAQ:ITEK), a clinical-stage biopharma focused on diseases of the eye, are having a tough start to the new year. Shares are collapsing in early-morning trading on Tuesday, falling more than 68% as of 10:05 a.m EST after the company reported results from a […]

Read More ˃
Cempra, Inc. (NASDAQ:CEMP) Shares Tank Following Concerns of Drug Approval Delay

Cempra, Inc. (NASDAQ:CEMP) Shares Tank Following Concerns of Drug Approval Delay

Clinical-stage drug company, Cempra, Inc. (NASDAQ:CEMP), was informed by the USFDA that it cannot approve its newest drug without additional data. Shares of clinical-stage drug company Cempra Inc. cratered Thursday, after the U.S. Food and Drug Administration said it cannot approve a pneumonia drug without additional safety data and improvements at a manufacturing facility. Shares of the Chapel Hill, N.C.–based company closed down 57% to $2.60, boosting year-to-date losses to […]

Read More ˃
Tetralogic Pharmaceuticals, Corp. (OTCMKTS:TLOG) Explodes Following Announcement of Completion of Sale

Tetralogic Pharmaceuticals, Corp. (OTCMKTS:TLOG) Explodes Following Announcement of Completion of Sale

Clinical-stage pharmaceutical company, Tetralogic Pharmaceuticals, Corp. (OTCMKTS:TLOG), announces that, alongside its subsidiary TetraLogic Research and Development Corporation, it has completed a sale for $12 million. PAOLI, Pa., Dec. 29, 2016 (GLOBE NEWSWIRE) — TetraLogic Pharmaceuticals Corporation (TLOG) (“TetraLogic” or “Company”) and its wholly-owned subsidiary TetraLogic Research and Development Corporation (“TDRC”) today announced that they have completed the sale to Medivir AB (Nasdaq Stockholm:MVIR) (“Medivir”) of their SMAC mimetic program, including […]

Read More ˃
Prima BioMed, Ltd. (NASDAQ:PBMD) on the Rise Following Release of First Clinical Data

Prima BioMed, Ltd. (NASDAQ:PBMD) on the Rise Following Release of First Clinical Data

Medical biotech company, Prima BioMed, Ltd. (NASDAQ:PBMD), has released interim data for its most recent clinical trial program. SYDNEY, AUSTRALIA–(Marketwired – Dec 29, 2016) – Prima BioMed Ltd (ASX : PRR) (NASDAQ : PBMD) (“Prima” or the “Company”) today announced interim data for its TACTI-mel (Two ACTive Immunotherapeutics in melanoma) clinical trial program for IMP321 in unresectable or metastatic melanoma patients. The Database Safety Monitoring Board (DSMB) confirmed that IMP321 […]

Read More ˃
NeuroMetrix, Inc. (NASDAQ:NURO) Advances Upon Announcement of $7.0 Million Private Placement

NeuroMetrix, Inc. (NASDAQ:NURO) Advances Upon Announcement of $7.0 Million Private Placement

Commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes, NeuroMetrix, Inc. (NASDAQ:NURO), announces that it has entered into a purchase agreement of 7,000 private shares and 10 million shares of private stock to a dedicated institutional investor totaling $7 million. WALTHAM, Mass.–(BUSINESS WIRE)– NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it has entered into a […]

Read More ˃
Shares of Galena Biopharma, Inc. (NASDAQ:GALE) Explode Upon Confirmation of Regulatory Pathway to Advance Trial

Shares of Galena Biopharma, Inc. (NASDAQ:GALE) Explode Upon Confirmation of Regulatory Pathway to Advance Trial

Biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs, Galena Biopharma, Inc. (NASDAQ:GALE), announces GALE-401 will advance into a Phase 3 trial. SAN RAMON, Calif., Dec. 28, 2016 (GLOBE NEWSWIRE) — Galena Biopharma, Inc. (GALE), a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs, today announced the Company has confirmed the […]

Read More ˃
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) in the Tank on Poor Phase III Sollpura Data

Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) in the Tank on Poor Phase III Sollpura Data

Biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases, Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), releases poor phase III Sollpura data, causing its share price to plummet. Anthera Pharmaceuticals, Inc. ANTH announced disappointing top-line data from a phase III study – SOLUTION – on one of its pipeline candidates, Sollpura (liprotamase), in cystic fibrosis patients with exocrine pancreatic insufficiency (EPI). Shares of the […]

Read More ˃
Shares of Micronet Enertec Technologies, Inc. (NASDAQ:MICT) Up Big After Receiving $1,060,000 Purchase Order

Shares of Micronet Enertec Technologies, Inc. (NASDAQ:MICT) Up Big After Receiving $1,060,000 Purchase Order

Designer, developer, manufacturer and seller of rugged mobile computing devices, Micronet Enertec Technologies, Inc. (NASDAQ:MICT), announces that its subsidiary has received a P.O. valued at approx. $1,060,000 for a recently released product. MONTVALE, N.J., Dec. 28, 2016 /PRNewswire/ — Micronet Enertec Technologies, Inc. (MICT) announced today that its Mobile Resource Management (MRM) subsidiary Micronet, (via Micronet Inc., its fully owned subsidiary) received a continuous purchase order valued at approximately $1,060,000 […]

Read More ˃
Shares of Microvision, Inc. (NASDAQ:MVIS) on the Rise as It Begins Shipping Small Form Factor Display Engine Samples to Customers

Shares of Microvision, Inc. (NASDAQ:MVIS) on the Rise as It Begins Shipping Small Form Factor Display Engine Samples to Customers

Leader in innovative ultra-miniature projection display and sensing technology, Microvision, Inc. (NASDAQ:MVIS), announces that it has begun to ship samples of its new engine to customers. REDMOND, Wash.–(BUSINESS WIRE)– MicroVision, Inc. (MVIS), a leader in innovative ultra-miniature projection display and sensing technology, today announced that it has begun on-schedule customer shipments of samples of its new, small form factor display engine. This Smart News Release features multimedia. View the full […]

Read More ˃
RADA Electronic Industries Ltd. (NASDAQ:RADA) on the Move As it Expects Significant Growth in Sales of Tactical Radars for Active Protection Systems

RADA Electronic Industries Ltd. (NASDAQ:RADA) on the Move As it Expects Significant Growth in Sales of Tactical Radars for Active Protection Systems

Israel-based defense electronics contractor specializing in the development, production, and sales of Tactical Land Radars for Force and Border Protection, Inertial Navigation Systems and Avionics Systems for fighter aircraft and UAVs, RADA Electronic Industries Ltd. (NASDAQ:RADA), identifies the Active Protection Systems market as its next major sales target. NETANYA, Israel, Dec. 27, 2016 (GLOBE NEWSWIRE) — RADA Electronic Industries Ltd. (RADA) eyes the Active Protection Systems (APS) market as the […]

Read More ˃
Capnia, Inc. (NASDAQ:CAPN) Announces Merger With Essentialis to Create Rare Disease Therapeutics Company, How Will the Market React to the News?

Capnia, Inc. (NASDAQ:CAPN) Announces Merger With Essentialis to Create Rare Disease Therapeutics Company, How Will the Market React to the News?

Leading provider and developer of innovative healthcare products to be used for the screening, detection and treatment of medical conditions, Capnia, Inc. (NASDAQ:CAPN), will create a new rare disease therapeutics company following merger with Essentialis. REDWOOD CITY, Calif. and CARLSBAD, Calif., Dec. 27, 2016 (GLOBE NEWSWIRE) — Capnia, Inc. (CAPN) and privately-held Essentialis, Inc. today announced their entry into a definitive merger agreement to create a rare disease therapeutics company.  […]

Read More ˃
Prima BioMed, Ltd (NASDAQ:PBMD) Announces Data From IMP321 AIPAC Clinical Trial in Breast Cancer, How Will the Market React to the Update?

Prima BioMed, Ltd (NASDAQ:PBMD) Announces Data From IMP321 AIPAC Clinical Trial in Breast Cancer, How Will the Market React to the Update?

Globally active biotechnology company that is striving to become a leader in the development of immunotherapeutic products for the treatment of cancer, Prima BioMed, Ltd (NASDAQ:PBMD), provides an update from its latest trial. SYDNEY, AUSTRALIA–(Marketwired – Dec 21, 2016) – Prima BioMed Ltd (ASX : PRR) (NASDAQ : PBMD) (“Prima” or the “Company”) today announced interim data from the AIPAC Phase IIb clinical trial for IMP321 in metastatic breast cancer […]

Read More ˃
Lightbridge, Corp. (NASDAQ:LTBR) Looks to Advance Following Approval of Norway 123 Agreement

Lightbridge, Corp. (NASDAQ:LTBR) Looks to Advance Following Approval of Norway 123 Agreement

U.S. nuclear fuel technology company, Lightbridge, Corp. (NASDAQ:LTBR), reveals that the U.S. government has approved renewal of an agreement with Norway, clearing the way for the company to use Norway’s research reactor. RESTON, Va., Dec. 21, 2016 (GLOBE NEWSWIRE) — Lightbridge Corporation (LTBR), a U.S. nuclear fuel technology company, today announced that the U.S. government has approved renewal of a 123 Agreement between the United States and Norway, which enables […]

Read More ˃
LightPath Technologies, Inc. (NASDAQ:LPTH) Jumps After Completing Acquisition of ISP Optics Corporation

LightPath Technologies, Inc. (NASDAQ:LPTH) Jumps After Completing Acquisition of ISP Optics Corporation

Leading vertically integrated global manufacturer, LightPath Technologies, Inc. (NASDAQ:LPTH), announces it has completed the acquisition of ISP Optics, Corp. ORLANDO, FL–(Marketwired – Dec 21, 2016) – LightPath Technologies, Inc. (NASDAQ : LPTH ) (“LightPath,” the “Company,” or “we”), a leading vertically integrated global manufacturer, distributor, and integrator of proprietary optical and infrared components and high-level assemblies, today announced that it has completed the acquisition of ISP Optics Corporation (“ISP”) for […]

Read More ˃
Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Advances After Entering Into Share Purchase Agreement With Otic Pharma

Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Advances After Entering Into Share Purchase Agreement With Otic Pharma

Biopharmaceutical company previously focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), announces agreement with Otic Pharma. BOSTON, Mass., IRVINE, Calif., & REHOVOT, Israel–(BUSINESS WIRE)– Tokai Pharmaceuticals Inc. (TKAI) and Otic Pharma Ltd., a privately-held, clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT), today announced that the two […]

Read More ˃
Shares of OvaScience, Inc. (NASDAQ:OVAS) Plunge After it Cuts 30% of Workforce, New CEO Resigns

Shares of OvaScience, Inc. (NASDAQ:OVAS) Plunge After it Cuts 30% of Workforce, New CEO Resigns

Waltham, MA-based OvaScience, Inc. (NASDAQ:OVAS), has laid off a third of its workforce and CEO, Harald Stock steps down, sending shares down the well. Waltham biotech OvaScience is laying off almost a third of its workforce, likely around 30 employees, and its CEO is resigning after less than six months on the job as the company slows efforts to expand its fertility treatments globally. The company’s share price fell about […]

Read More ˃
Celsion Corporation Announces $1.8 Million Registered Direct Offering, How Will This News Affect the Share Price?

Celsion Corporation Announces $1.8 Million Registered Direct Offering, How Will This News Affect the Share Price?

Celsion, Corp. (NASDAQ:CLSN) has entered into a definitive agreement with several investors to purchase approximately $1.8 million in shares of common stock. LAWRENCEVILLE, N.J., Dec. 20, 2016 (GLOBE NEWSWIRE) — Celsion Corporation (the “Company”) (CLSN) today announced that it has entered into a definitive agreement with several institutional investors to purchase an aggregate of approximately $1.8 million of shares of common stock in a registered direct offering. The Company agreed […]

Read More ˃
xG Technology, Inc. (NASDAQ:XGTI) Prices $10,000,000 Public Offering, Shares Plummet

xG Technology, Inc. (NASDAQ:XGTI) Prices $10,000,000 Public Offering, Shares Plummet

Leader in providing critical wireless communications for use in challenging operating environments, xG Technology, Inc. (NASDAQ:XGTI), announces pricing of public offering of approximately $10 million. SARASOTA, Fla., Dec. 21, 2016 /PRNewswire/ — xG Technology, Inc. (“xG”) (XGTI), a leader in providing critical wireless communications for use in challenging operating environments, today announced the pricing of an underwritten public offering with expected total gross proceeds of approximately $10,000,000 before deducting underwriting […]

Read More ˃
Shares of Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) Rise Following Announcement of Partnership Launch Program With FocusScript

Shares of Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) Rise Following Announcement of Partnership Launch Program With FocusScript

Pharmaceutical company dedicated to producing and dispensing high quality innovative compounded medications in all 50 states, Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY), announces joint launch of the Correct Compound program. SAN DIEGO and CREVE COEUR, Mo., Dec. 21, 2016 /PRNewswire/ — Imprimis Pharmaceuticals, Inc. (IMMY) and Focus Script, LLC, a leading independent specialized pharmacy claims management company, today announced the joint launch of the Correct Compound™ program. The Correct Compound program is […]

Read More ˃
Sysorex Global (NASDAQ:SYRX) Launches New Webinar Series; Stocks Advance on News

Sysorex Global (NASDAQ:SYRX) Launches New Webinar Series; Stocks Advance on News

Indoor positioning and data analytics company, Sysorex Global (NASDAQ:SYRX), announces the launch of a new webinar series entitled “Freethinkers of the Retail World.” PALO ALTO, Calif.–(BUSINESS WIRE)– Sysorex (SYRX), the indoor positioning and data analytics company, today announced the launch of its 3-part webinar series titled “Freethinkers of the Retail World.” The webinar series, to kick off in early January 2017, will address challenges facing the retail industry during the […]

Read More ˃